The lung cancer vaccine race has brought together an unusual mix of players. Merck KGaA was in a good position, but its vaccine disappointed in Phase III, while GlaxoSmithKline could report data on its candidate this year. Then there is the Cuba-Argentina joint venture.
Luminex has inked a long-term agreement with Merck KGaA's life sciences business, tasking the German company with providing assays for Luminex's research technology.
Amid repeated pipeline struggles and an R&D re-think, Merck KGaA has signed an exclusive deal with the newly public Quintiles, launching a novel collaboration that will give the CRO a seat at the decisionmaking table.
Mylan has had an on-again, off-again relationship with the former Dey plant in Napa County, CA. The plan to close it is back on and by year's end the lights will be off.
Novartis' ($NVS) vaccine business is hanging in the balance, relying on the potential approval of a shot to protect against a meningitis-causing bacteria to keep the unit afloat.
The CMO units of Merck KGaA and Boehringer Ingelheim are investing in single-use, disposable technolgies in their manufacturing processes, saying the move will help their clients get drugs on the market faster than traditional methods.
With drug companies looking for ways to get to market faster and start realizing revenue streams sooner, two European contract manufacturers are touting single-use, disposable technology that they claim will help customers do just that.
Putting some specifics to plans it announced in February to cut its workforce about 10%, Merck KGaA says two production facilities will be closed as part of the downsizing.
Molecular diagnostics firm MDxHealth has inked a development and commercialization deal with Merck KGaA, looking to market a companion diagnostic test for one of the drugmaker's cancer treatments.
Well it's done. Merck KGaA put the finishing touches on a restructuring plan for Merck Serono that closes the Geneva half of its two-headquarters setup, but which leaves its manufacturing operations in Switzerland mostly intact.